836 related articles for article (PubMed ID: 27092912)
1. Medication-Related Osteonecrosis of the Jaw Around Dental Implants: Implant Surgery-Triggered or Implant Presence-Triggered Osteonecrosis?
Giovannacci I; Meleti M; Manfredi M; Mortellaro C; Greco Lucchina A; Bonanini M; Vescovi P
J Craniofac Surg; 2016 May; 27(3):697-701. PubMed ID: 27092912
[TBL] [Abstract][Full Text] [Related]
2. Medication-related osteonecrosis of the jaw: risk factors in patients under biphosphonate versus patients under antiresorptive-antiangiogenic drugs.
Ghidini G; Manfredi M; Giovannacci I; Mergoni G; Sarraj A; Mureddu M; Giunta G; Bonanini M; Meleti M; Vescovi P
Minerva Stomatol; 2017 Aug; 66(4):135-140. PubMed ID: 28497661
[TBL] [Abstract][Full Text] [Related]
3. Outcomes of placing dental implants in patients taking oral bisphosphonates: a review of 115 cases.
Grant BT; Amenedo C; Freeman K; Kraut RA
J Oral Maxillofac Surg; 2008 Feb; 66(2):223-30. PubMed ID: 18201600
[TBL] [Abstract][Full Text] [Related]
4. Osteonecrosis and spontaneous exfoliation of dental implants associated with oral bisphosphonate therapy: a case report.
Rawal SY; Hilal G
Aust Dent J; 2020 Mar; 65(1):100-103. PubMed ID: 31769879
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and risk factors of medication-related osteonecrosis of the jaw in osteoporotic and breast cancer patients: a cross-sectional study.
Soares AL; Simon S; Gebrim LH; Nazário ACP; Lazaretti-Castro M
Support Care Cancer; 2020 May; 28(5):2265-2271. PubMed ID: 31468192
[TBL] [Abstract][Full Text] [Related]
6. Osteopathology induced by bisphosphonates and dental implants: clinical observations.
Jacobsen C; Metzler P; Rössle M; Obwegeser J; Zemann W; Grätz KW
Clin Oral Investig; 2013 Jan; 17(1):167-75. PubMed ID: 22415216
[TBL] [Abstract][Full Text] [Related]
7. Osteonecrosis associated with dental implants in patients undergoing bisphosphonate treatment.
Kwon TG; Lee CO; Park JW; Choi SY; Rijal G; Shin HI
Clin Oral Implants Res; 2014 May; 25(5):632-40. PubMed ID: 23278625
[TBL] [Abstract][Full Text] [Related]
8. Clinical and Radiographic Outcomes of Dental Implants in Patients Treated With Antiresorptive Drugs: A Consecutive Case Series.
Otto S; Schnoedt EM; Troeltzsch M; Kaeppler G; Aljohani S; Liebermann A; Fliefel R
J Oral Implantol; 2023 Feb; 49(1):39-45. PubMed ID: 35446931
[TBL] [Abstract][Full Text] [Related]
9. Osteonecrosis of the jaw after implant surgery in patients treated with bisphosphonates--a presentation of six consecutive cases.
Tam Y; Kar K; Nowzari H; Cha HS; Ahn KM
Clin Implant Dent Relat Res; 2014 Oct; 16(5):751-61. PubMed ID: 23445465
[TBL] [Abstract][Full Text] [Related]
10. Incidence and risk factors associated to Medication-Related Osteo Necrosis of the Jaw (MRONJ) in patients with osteoporosis after tooth extractions. A 12-months observational cohort study.
Cuozzo A; Iorio-Siciliano V; Vaia E; Mauriello L; Blasi A; Ramaglia L
J Stomatol Oral Maxillofac Surg; 2022 Nov; 123(6):616-621. PubMed ID: 35609780
[TBL] [Abstract][Full Text] [Related]
11. What is the effect of anti-resorptive drugs (ARDs) on the development of medication-related osteonecrosis of the jaw (MRONJ) in osteoporosis patients: A systematic review.
Aljohani S; Fliefel R; Ihbe J; Kühnisch J; Ehrenfeld M; Otto S
J Craniomaxillofac Surg; 2017 Sep; 45(9):1493-1502. PubMed ID: 28687467
[TBL] [Abstract][Full Text] [Related]
12. What impact do systemically administrated bisphosphonates have on oral implant therapy? A systematic review.
Madrid C; Sanz M
Clin Oral Implants Res; 2009 Sep; 20 Suppl 4():87-95. PubMed ID: 19663954
[TBL] [Abstract][Full Text] [Related]
13. Factors affecting development of medication-related osteonecrosis of the jaw in cancer patients receiving high-dose bisphosphonate or denosumab therapy: Is tooth extraction a risk factor?
Soutome S; Hayashida S; Funahara M; Sakamoto Y; Kojima Y; Yanamoto S; Umeda M
PLoS One; 2018; 13(7):e0201343. PubMed ID: 30048523
[TBL] [Abstract][Full Text] [Related]
14. Survival of dental implants among post-menopausal female dental school patients taking oral bisphosphonates: a retrospective study.
Famili P; Quigley S; Mosher T
Compend Contin Educ Dent; 2011; 32(6):E106-9. PubMed ID: 23738968
[TBL] [Abstract][Full Text] [Related]
15. Oral bisphosphonate-associated osteonecrosis of the jaw after implant surgery: a case report and literature review.
Bedogni A; Bettini G; Totola A; Saia G; Nocini PF
J Oral Maxillofac Surg; 2010 Jul; 68(7):1662-6. PubMed ID: 20561470
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of dental implants as a risk factor for the development of bisphosphonate-related osteonecrosis of the jaw in breast cancer patients.
Matsuo A; Hamada H; Takahashi H; Okamoto A; Kaise H; Chikazu D
Odontology; 2016 Sep; 104(3):363-71. PubMed ID: 25956267
[TBL] [Abstract][Full Text] [Related]
17. Is implant surgery a risk factor for osteonecrosis of the jaw in older adult patients with osteoporosis? A national cohort propensity score-matched study.
Ryu JI; Kim HY; Kwon YD
Clin Oral Implants Res; 2021 Apr; 32(4):437-447. PubMed ID: 33452837
[TBL] [Abstract][Full Text] [Related]
18. Is medication related osteonecrosis of the jaw around implants a rare entity? A case series with a focus on etiopathophysiology.
Massaad J; Magremanne M
J Stomatol Oral Maxillofac Surg; 2022 Nov; 123(6):e743-e748. PubMed ID: 34922047
[TBL] [Abstract][Full Text] [Related]
19. Dental implants as risk factors for patients with medication-related osteonecrosis of the jaws (MRONJ).
Pichardo SEC; van der Hee JG; Fiocco M; Appelman-Dijkstra NM; van Merkesteyn JPR
Br J Oral Maxillofac Surg; 2020 Sep; 58(7):771-776. PubMed ID: 32631756
[TBL] [Abstract][Full Text] [Related]
20. Failure risk estimates after dental implants placement associated with plasma rich in growth factor-Endoret in osteoporotic women under bisphosphonate therapy.
Mozzati M; Arata V; Giacomello M; Del Fabbro M; Gallesio G; Mortellaro C; Bergamasco L
J Craniofac Surg; 2015 May; 26(3):749-55. PubMed ID: 25974785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
